Wentink, Madelon Q <br/><br/>
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  11 2016 
 - 12532-12537 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1610258113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Angiogenesis Inhibitors--immunology<br/>Animals<br/>Antibodies, Neutralizing--immunology<br/>Bevacizumab--immunology<br/>Binding Sites--immunology<br/>Cell Line, Tumor<br/>Colonic Neoplasms--drug therapy<br/>Cross Reactions--immunology<br/>Humans<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Molecular Targeted Therapy--methods<br/>Peptides--chemistry<br/>Rats, Wistar<br/>Vaccination--methods<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays